A severely immunocompromised child with uncomplicated oseltamivir-resistant 2009 H1N1 pandemic influenza infection

Use of Intravenous Zanamivir after Development of Oseltamivir Resistance in a Critically Ill Immunosuppressed Child Infected with 2009 Pandemic Influenza A (H1N1) Virus

(2010) Daniel E. Dulek et al.   CLINICAL INFECTIOUS DISEASES

Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study

(2010) Deepali Kumar et al.   LANCET INFECTIOUS DISEASES

Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance

(2010) J. D. Bloom et al.   SCIENCE

Pandemic H1N1 2009 Influenza A Virus Induces Weak Cytokine Responses in Human Macrophages and Dendritic Cells and Is Highly Sensitive to the Antiviral Actions of Interferons

(2009) P. Osterlund et al.   JOURNAL OF VIROLOGY

H1N1 pneumonitis treated with intravenous zanamivir

(2009) I Michael Kidd et al.   LANCET

Innate immunity to influenza virus: implications for future therapy

(2008) Mitchell R White et al.   Expert Review of Clinical Immunology